PT1317273E - Utilizacao de quimera il-6r/il-6 na doenca de huntington - Google Patents
Utilizacao de quimera il-6r/il-6 na doenca de huntingtonInfo
- Publication number
- PT1317273E PT1317273E PT01972039T PT01972039T PT1317273E PT 1317273 E PT1317273 E PT 1317273E PT 01972039 T PT01972039 T PT 01972039T PT 01972039 T PT01972039 T PT 01972039T PT 1317273 E PT1317273 E PT 1317273E
- Authority
- PT
- Portugal
- Prior art keywords
- chimera
- huntington
- disease
- derivative
- mutein
- Prior art date
Links
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 108090001005 Interleukin-6 Proteins 0.000 abstract 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00120045 | 2000-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1317273E true PT1317273E (pt) | 2006-09-29 |
Family
ID=8169836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT01972039T PT1317273E (pt) | 2000-09-14 | 2001-09-10 | Utilizacao de quimera il-6r/il-6 na doenca de huntington |
Country Status (13)
Country | Link |
---|---|
US (3) | US20040057928A1 (pt) |
EP (1) | EP1317273B1 (pt) |
JP (1) | JP5030364B2 (pt) |
AT (1) | ATE324906T1 (pt) |
AU (2) | AU2001291849B2 (pt) |
CA (1) | CA2419954C (pt) |
CY (1) | CY1105116T1 (pt) |
DE (1) | DE60119347T2 (pt) |
DK (1) | DK1317273T3 (pt) |
ES (1) | ES2262680T3 (pt) |
IL (2) | IL154777A0 (pt) |
PT (1) | PT1317273E (pt) |
WO (1) | WO2002022149A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL147412A0 (en) * | 2001-12-31 | 2002-08-14 | Yeda Res & Dev | The use of il6r/il6 chimera in nerve cell regeneration |
AU2003275846A1 (en) * | 2002-10-24 | 2004-05-13 | The University Of British Columbia | Methods for neuroprotection |
US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
JP4878553B2 (ja) * | 2003-06-12 | 2012-02-15 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | オリゴデンドロサイト分化の促進 |
EP1675871A2 (en) | 2003-10-10 | 2006-07-05 | Xencor Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
WO2013184942A1 (en) | 2012-06-08 | 2013-12-12 | Alkermes, Inc. | Ligands modified by circular permutation as agonists and antagonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637483A (en) * | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
IL99803A (en) * | 1991-10-20 | 1997-02-18 | Yeda Res & Dev | Pharmaceutical compositions comprising interleukin-6 for the treatment of chronic lymphocytic leukemia and B-cell lymphomas |
US5792900A (en) * | 1991-10-21 | 1998-08-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for producing and using homogenous neuronal cell transplants |
IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
CN1322137C (zh) * | 1997-12-22 | 2007-06-20 | 牛津生物医学(英国)有限公司 | 基于马传染性贫血病毒(eiav)的逆转录病毒载体 |
JP4859153B2 (ja) * | 1999-02-25 | 2012-01-25 | 東ソー株式会社 | 新規神経系細胞分化促進剤 |
IL130586A0 (en) * | 1999-06-21 | 2000-06-01 | Yeda Res & Dev | IL6RIL6 chimera for the treatment of demyelinating diseases |
-
2001
- 2001-09-10 CA CA2419954A patent/CA2419954C/en not_active Expired - Lifetime
- 2001-09-10 AT AT01972039T patent/ATE324906T1/de active
- 2001-09-10 EP EP01972039A patent/EP1317273B1/en not_active Expired - Lifetime
- 2001-09-10 JP JP2002526399A patent/JP5030364B2/ja not_active Expired - Fee Related
- 2001-09-10 PT PT01972039T patent/PT1317273E/pt unknown
- 2001-09-10 AU AU2001291849A patent/AU2001291849B2/en not_active Ceased
- 2001-09-10 IL IL15477701A patent/IL154777A0/xx unknown
- 2001-09-10 DK DK01972039T patent/DK1317273T3/da active
- 2001-09-10 US US10/380,427 patent/US20040057928A1/en not_active Abandoned
- 2001-09-10 DE DE60119347T patent/DE60119347T2/de not_active Expired - Lifetime
- 2001-09-10 AU AU9184901A patent/AU9184901A/xx active Pending
- 2001-09-10 WO PCT/EP2001/010442 patent/WO2002022149A1/en active IP Right Grant
- 2001-09-10 ES ES01972039T patent/ES2262680T3/es not_active Expired - Lifetime
-
2003
- 2003-03-06 IL IL154777A patent/IL154777A/en not_active IP Right Cessation
-
2006
- 2006-07-28 CY CY20061101058T patent/CY1105116T1/el unknown
-
2007
- 2007-01-11 US US11/622,284 patent/US20070172454A1/en not_active Abandoned
-
2010
- 2010-03-04 US US12/717,305 patent/US8329654B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60119347T2 (de) | 2007-02-22 |
US20070172454A1 (en) | 2007-07-26 |
IL154777A (en) | 2010-11-30 |
IL154777A0 (en) | 2003-10-31 |
EP1317273A1 (en) | 2003-06-11 |
CY1105116T1 (el) | 2009-11-04 |
US20100166703A1 (en) | 2010-07-01 |
US8329654B2 (en) | 2012-12-11 |
DE60119347D1 (de) | 2006-06-08 |
EP1317273B1 (en) | 2006-05-03 |
JP5030364B2 (ja) | 2012-09-19 |
DK1317273T3 (da) | 2006-09-04 |
ATE324906T1 (de) | 2006-06-15 |
AU2001291849B2 (en) | 2005-11-24 |
ES2262680T3 (es) | 2006-12-01 |
JP2004508409A (ja) | 2004-03-18 |
AU9184901A (en) | 2002-03-26 |
US20040057928A1 (en) | 2004-03-25 |
CA2419954A1 (en) | 2002-03-21 |
CA2419954C (en) | 2012-01-03 |
WO2002022149A1 (en) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2002000429A (es) | Imidazotriazinas | |
BR0208636A (pt) | Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com infncia | |
BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
BR0213358A (pt) | Uso de flibanserina | |
NO330934B1 (no) | Flytende farmasoytisk preparat samt anvendelse og fremstilling derav. | |
ES2058892T3 (es) | Uso de omeprazol como agente antimicrobiano. | |
ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
BR0109272A (pt) | Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos | |
BRPI0410029A (pt) | dihidroquinazolinas substituìdas | |
BRPI0414215A (pt) | tienopirazóis | |
CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
CY1105116T1 (el) | Χρηση των il-6r/il-6 χιμαιρων στη νοσο του huntington | |
BR0012291A (pt) | Fenoxifluorpirimidinas | |
DK1228097T3 (da) | Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge | |
BR9913337A (pt) | Derivados tan-1057 | |
SE0002729D0 (sv) | Novel compound form | |
ATE390124T1 (de) | Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin | |
MXPA02006511A (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido. | |
BR0210910A (pt) | Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes | |
CY1106363T1 (el) | Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων | |
SE0000303D0 (sv) | Novel compounds | |
RS51316B (sr) | Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli | |
DK1012286T3 (da) | Allelvariant af humant STAT3 | |
MEP39708A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine |